| 1 |
孙枫, 彭佳楠, 郭晓燕, 等. 慢性肾脏病透析患者肌少症的研究进展 [J]. 中国临床实用医学, 2023, 14(3): 75-77.
|
| 2 |
Cawthon PM, Lui LY, Taylor BC, et al. Clinical definitions of sarcopenia and risk of hospitalization in community-dwelling older men: the osteoporotic fractures in men study [J]. J Gerontol A Biol Sci Med Sci, 2017, 72(10): 1383-1389.
|
| 3 |
Cruz-Jentoft AJ, Bahat G, Bauer J, et al. Sarcopenia: revised European consensus on definition and diagnosis [J]. Age Ageing, 2019, 48(4): 601.
|
| 4 |
王家圆, 王晓东. 消化系统恶性肿瘤相关肌少症的研究进展[J/OL]. 中华临床医师杂志(电子版), 2023, 17(7): 823-827.
|
| 5 |
马金栋, 焦向飞, 蔡婷婷, 等. 肌肉减少症与肝癌研究进展[J/OL]. 中华临床医师杂志(电子版), 2023, 17(3): 356-359.
|
| 6 |
Gulcicek S, Seyahi N. Factors associated with sarcopenia in patients with chronic kidney disease: A cross-sectional single-center study [J]. Med Sci Monit, 2023, 29: e939457.
|
| 7 |
Mori K, Nishide K, Okuno S, et al. Impact of diabetes on sarcopenia and mortality in patients undergoing hemodialysis [J]. BMC Nephrology, 2019, 20(1): 105.
|
| 8 |
Thomas SS, Mitch WE. Mechanisms stimulating muscle wasting in chronic kidney disease: the roles of the ubiquitin-proteasome system and myostatin [J]. Clin Exp Nephrol, 2013, 17(2): 174-182.
|
| 9 |
Niida Y, Masuda M, Adachi Y, et al. Reduction of stearoyl-CoA desaturase (SCD) contributes muscle atrophy through the excess endoplasmic reticulum stress in chronic kidney disease [J]. J Clin Biochem Nutr, 2020, 67(2): 179-187.
|
| 10 |
Taketani Y, Koiwa F, Yokoyama K. Management of phosphorus load in CKD patients [J]. Clin Exp Nephrol, 2017, 21(Suppl 1): 27-36.
|
| 11 |
Imi Y, Yabiki N, Abuduli M, et al. High phosphate diet suppresses lipogenesis in white adipose tissue [J]. J Clin Biochem Nutr, 2018, 63(3): 181-191.
|
| 12 |
McCroskery S, Thomas M, Maxwell L, et al. Myostatin negatively regulates satellite cell activation and self-renewal [J]. J Cell Biol, 2003, 162(6): 1135-1147.
|
| 13 |
Thome T, Kumar RA, Burke SK, et al. Impaired muscle mitochondrial energetics is associated with uremic metabolite accumulation in chronic kidney disease [J]. Jci Insight, 2021, 6(1): e139826.
|
| 14 |
Xu C, Kasimumali A, Guo X, et al. Reduction of mitochondria and up regulation of pyruvate dehydrogenase kinase 4 of skeletal muscle in patients with chronic kidney disease [J]. Nephrology, 2020, 25(3): 230-238.
|
| 15 |
Thome T, Salyers ZR, Kumar RA, et al. Uremic metabolites impair skeletal muscle mitochondrial energetics through disruption of the electron transport system and matrix dehydrogenase activity [J]. Am J Physiol Cell Physiol, 2019, 317(4): C701-C713.
|
| 16 |
Watanabe H, Enoki Y, Maruyama T. Sarcopenia in chronic kidney disease: factors, mechanisms, and therapeutic interventions [J]. Biol Pharm Bull, 2019, 42(9): 1437-1445.
|
| 17 |
Abramowitz MK, Paredes W, Zhang K, et al. Skeletal muscle fibrosis is associated with decreased muscle inflammation and weakness in patients with chronic kidney disease [J]. Am J Physiol Renal Physiol, 2018, 315(6): F1658-F1669.
|
| 18 |
Acuña-Castroviejo D, Rahim I, Acuña-Fernández C, et al. Melatonin, clock genes and mitochondria in sepsis [J]. Cell Mol Life Sci, 2017, 74(21): 3965-3987.
|
| 19 |
Martin RA, Viggars MR, Esser KA. Metabolism and exercise: the skeletal muscle clock takes centre stage [J]. Nat Rev Endocrinol, 2023, 19(5): 272-284.
|
| 20 |
Fernández-Martínez J, Ramírez-Casas Y, Aranda-Martínez P, et al. iMS-Bmal1-/- mice show evident signs of sarcopenia that are counteracted by exercise and melatonin therapies [J]. J Pineal Res, 2024, 76(1): e12912.
|
| 21 |
蒲蕾, 冯韵霖, 洪大情, 等. 蛋白质-能量消耗对血液透析患者预后的影响 [J/OL]. 中华临床医师杂志(电子版), 2023, 17(10): 1051-1057.
|
| 22 |
Damanti S, Azzolino D, Roncaglione C, et al. Efficacy of nutritional interventions as stand-alone or synergistic treatments with exercise for the management of sarcopenia [J]. Nutrients, 2019, 11(9): 1991.
|
| 23 |
Kashyap S, Shivakumar N, Varkey A, et al. Ileal digestibility of intrinsically labeled hen's egg and meat protein determined with the dual stable isotope tracer method in Indian adults [J]. Am J Clin Nutr, 2018, 108(5): 980-987.
|
| 24 |
Kashyap S, Varkey A, Shivakumar N, et al. True ileal digestibility of legumes determined by dual-isotope tracer method in Indian adults [J]. Am J Clin Nutr, 2019, 110(4): 873-882.
|
| 25 |
Pereira SL, Shoemaker ME, Gawel S, et al. Biomarker changes in response to a 12-week supplementation of an oral nutritional supplement enriched with protein, vitamin D and HMB in malnourished community dwelling older adults with sarcopenia [J]. Nutrients, 2022, 14(6): 1196.
|
| 26 |
Caballero-García A, Pascual-Fernández J, Noriega-González DC, et al. L-Citrulline supplementation and exercise in the management of sarcopenia [J]. Nutrients, 2021, 13(9): 3133.
|
| 27 |
Cheng Z, Lin J, Qian Q. Role of vitamin D in cognitive function in chronic kidney disease [J]. Nutrients, 2016, 8(5): 291.
|
| 28 |
Molina P, Carrero JJ, Bover J, et al. Vitamin D, a modulator of musculoskeletal health in chronic kidney disease [J]. J Cachexia Sarcopenia Muscle, 2017, 8(5): 686-701.
|
| 29 |
Deutz NEP, Bauer JM, Barazzoni R, et al. Protein intake and exercise for optimal muscle function with aging: Recommendations from the ESPEN Expert Group [J]. Clinical Nutrition, 2014, 33(6): 929-936.
|
| 30 |
Bauer J, Biolo G, Cederholm T, et al. Evidence-based recommendations for optimal dietary protein intake in older people: a position paper from the PROT-AGE Study Group [J]. J Am Med Dir Assoc, 2013, 14(8): 542-559.
|
| 31 |
Ko GJ, Obi Y, Tortorici AR, et al. Dietary protein intake and chronic kidney disease [J]. Curr Opin Clin Nutr Metab Care, 2017, 20(1): 77-85.
|
| 32 |
Chang G, Shih HM, Pan CF, et al. Effect of low protein diet supplemented with ketoanalogs on endothelial function and protein-bound uremic toxins in patients with chronic kidney disease [J]. Biomedicines, 2023, 11(5): 1312.
|
| 33 |
Murphy CH, McCarthy SN, Roche HM. Nutrition strategies to counteract sarcopenia: a focus on protein, LC n-3 PUFA and precision nutrition [J]. Proc Nutr Soc, 2023, 82(3): 419-431.
|
| 34 |
Twycross-Lewis R, Kilduff LP, Wang G, et al. The effects of creatine supplementation on thermoregulation and physical (cognitive) performance: a review and future prospects [J]. Amino Acids, 2016, 48(8): 1843-1855.
|
| 35 |
Sharma B, Yadav DK. L-carnitine and chronic kidney disease: a comprehensive review on nutrition and health perspectives [J]. J Pers Med, 2023, 13(2): 298.
|
| 36 |
Czaya B, Heitman K, Campos I, et al. Hyperphosphatemia increases inflammation to exacerbate anemia and skeletal muscle wasting independently of FGF23-FGFR4 signaling [R]. Cell Biology, 2022, 18(11): e74782
|
| 37 |
Widmann M, Nieß AM, Munz B. Physical exercise and epigenetic modifications in skeletal muscle [J]. Sports Medicine, 2019, 49(4): 509-523.
|
| 38 |
Watson EL, Gould DW, Wilkinson TJ, et al. Twelve-week combined resistance and aerobic training confers greater benefits than aerobic training alone in nondialysis CKD [J]. Am J Physiol Renal Physiol, 2018, 314(6): F1188-F1196.
|
| 39 |
Noor H, Reid J, Slee A. Resistance exercise and nutritional interventions for augmenting sarcopenia outcomes in chronic kidney disease: a narrative review [J]. J Cachexia Sarcopenia Muscle, 2021, 12(6): 1621-1640.
|
| 40 |
Fuzari HK, Dornelas de Andrade A, A Rodrigues M, et al. Whole body vibration improves maximum voluntary isometric contraction of knee extensors in patients with chronic kidney disease: A randomized controlled trial [J]. Physiother Theory Pract, 2019, 35(5): 409-418.
|
| 41 |
Dent E, Morley JE, Cruz-Jentoft AJ, et al. International clinical practice guidelines for sarcopenia (ICFSR): screening, diagnosis and management [J]. J Nutr Health Aging, 2018, 22(10): 1148-1161.
|
| 42 |
Macdonald JH, Marcora SM, Jibani MM, et al. Nandrolone decanoate as anabolic therapy in chronic kidney disease: a randomized phase II dose-finding study [J]. Nephron Clin Pract, 2007, 106(3): c125-135.
|
| 43 |
Feike Y, Zhijie L, Wei C. Advances in research on pharmacotherapy of sarcopenia [J]. Aging Medicine, 2021, 4(3): 221-233.
|
| 44 |
Coto-Montes A, Boga JA, Tan DX, et al. Melatonin as a potential agent in the treatment of sarcopenia [J]. Int J Mol Sci, 2016, 17(10): 1771.
|
| 45 |
Venegas C, García JA, Escames G, et al. Extrapineal melatonin: analysis of its subcellular distribution and daily fluctuations [J]. J Pineal Res, 2012, 52(2): 217-227.
|
| 46 |
Mannon EC, O'Connor PM. Alkali supplementation as a therapeutic in chronic kidney disease: what mediates protection? [J]. Am J Physiol Renal Physiol, 2020, 319(6): F1090-F1104.
|
| 47 |
Navaneethan SD, Shao J, Buysse J, et al. Effects of treatment of metabolic acidosis in CKD: a systematic review and meta-analysis [J]. Clin J Am Soc Nephrol, 2019, 14(7): 1011-1020.
|
| 48 |
Kim MY, Shin HY, Cho SC, et al. Silver electroceutical technology to treat sarcopenia [J]. Proc Natl Acad Sci U S A, 2023, 120(33): e2300036120.
|